Capital Investment Advisors LLC Sells 9,190 Shares of CVS Health Corporation $CVS

Capital Investment Advisors LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 11.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 68,894 shares of the pharmacy operator’s stock after selling 9,190 shares during the period. Capital Investment Advisors LLC’s holdings in CVS Health were worth $5,194,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CVS. Norges Bank bought a new position in CVS Health during the second quarter valued at $1,358,698,000. Invesco Ltd. lifted its position in shares of CVS Health by 15.3% during the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of CVS Health by 815.2% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock valued at $183,701,000 after buying an additional 2,372,121 shares during the last quarter. Kingstone Capital Partners Texas LLC purchased a new stake in CVS Health in the 2nd quarter worth about $155,185,000. Finally, Jennison Associates LLC raised its stake in CVS Health by 111.7% in the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock valued at $276,895,000 after acquiring an additional 2,117,798 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CVS shares. Sanford C. Bernstein reiterated a “market perform” rating and set a $91.00 target price on shares of CVS Health in a research report on Tuesday. TD Cowen raised their price objective on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, December 10th. UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Raymond James Financial increased their target price on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Finally, Wells Fargo & Company reduced their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Stock Performance

NYSE:CVS opened at $80.29 on Friday. The business has a 50 day moving average of $78.70 and a 200 day moving average of $73.83. The company has a market capitalization of $101.92 billion, a price-to-earnings ratio of 211.29, a PEG ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a 1-year low of $46.34 and a 1-year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the firm posted $1.09 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.